Valuation: Precipio, Inc.

Market Cap 4.51Cr 3.95Cr 3.63Cr 3.38Cr 6.41Cr 429.88Cr 6.51Cr 44Cr 17Cr 211.31Cr 17Cr 17Cr 728.16Cr P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 4.62Cr 4.03Cr 3.71Cr 3.46Cr 6.56Cr 439.42Cr 6.65Cr 45Cr 17Cr 216Cr 17Cr 17Cr 744.32Cr EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.41%
Yield 2024 *
-
Yield 2025 -
1 day+1.32%
1 week+12.74%
Current month+2.02%
1 month+12.37%
3 months-0.55%
6 months+6.05%
Current year+9.92%
1 week 22.26
Extreme 22.26
25.94
1 month 21.37
Extreme 21.3715
25.94
Current year 19.52
Extreme 19.52
33.63
1 year 12.46
Extreme 12.46
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Executive Officer 54 28/06/2017
Director of Finance/CFO 59 21/03/2022
Chief Tech/Sci/R&D Officer 42 01/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap.
21/05Sell

Chairman

-900 0.0505%
20/05Sell

Chairman

-2,534 0.1421%
15/04Free

Director

93 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+12.74%+123.60%+223.85% 4.51Cr
-1.95%+0.76%+2.59%-29.00% 1.67TCr
+5.89%+17.22%+43.79%+99.43% 168.36Cr
+0.39%+34.99%-39.53%-77.97% 124.45Cr
+0.06%+3.92%-28.55%+34.53% 113.8Cr
+1.31%-0.09%-25.81%-52.92% 63Cr
+0.21%-0.98%-39.13%-56.82% 58Cr
-0.66%+3.11%+21.67%-54.99% 45Cr
+1.79%-0.16%-55.52%-60.22% 38Cr
+2.52%+7.65%-20.35%-17.75% 35Cr
Average +1.01%+7.36%-1.72%+0.81% 231.7Cr
Weighted average by Cap. -1.24%+3.98%-0.71%-20.87%

Financials

2024 2025
Net sales 1.85Cr 1.62Cr 1.49Cr 1.39Cr 2.63Cr 176.45Cr 2.67Cr 18Cr 6.95Cr 87Cr 6.96Cr 6.81Cr 298.88Cr 2.4Cr 2.1Cr 1.93Cr 1.8Cr 3.42Cr 228.98Cr 3.47Cr 23Cr 9.02Cr 112.56Cr 9.03Cr 8.83Cr 387.86Cr
Net income -42.9L -37.5L -34.47L -32.13L -60.93L -41Cr -61.86L -4.14Cr -1.61Cr -20Cr -1.61Cr -1.58Cr -69Cr -4L -3L -3L -3L -5L -3.46Cr -5L -35.01L -13.61L -1.7Cr -13.63L -13.33L -5.85Cr
Net Debt -1L -1L -1L -1L -2L -1.29Cr -2L -13.12L -5L -63.65L -5L -5L -2.19Cr 10.02L 9L 8L 8L 14.23L 9.54Cr 14.45L 96.64L 37.57L 4.69Cr 37.61L 36.8L 16Cr
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
02/26/02 $25.26 +1.32% 6,893
01/26/01 $24.93 +0.69% 12,651
30/26/30 $24.76 +1.98% 16,216
29/26/29 $24.28 +4.16% 5,250
26/26/26 $23.31 +4.04% 54,316
  1. Stock Market
  2. Stocks
  3. PRPO Stock